R. Perez-Perez

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

John D. Davis, L. Purcell, G. Yancopoulos, 2021, The New England journal of medicine.

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.

John D. Davis, L. Purcell, G. Yancopoulos, 2022, JAMA.

Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention

L. Purcell, A. Baum, N. Stahl, 2021, medRxiv.

Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection

L. Purcell, A. Baum, N. Stahl, 2021, medRxiv.

Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial

John D. Davis, L. Purcell, G. Yancopoulos, 2021, medRxiv.